Morgan Stanley Scynexis Inc Transaction History

Morgan Stanley

$1.59 Trillion
Q3 2025

A detailed history of Morgan Stanley transactions in Scynexis Inc stock. As of the latest transaction made, Morgan Stanley holds 15,700 shares of SCYX stock, worth $9,263. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,700

Previous 15,700 -0.0%

Holding current value

$9,263

Previous $10,000 30.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 May 14, 2025	SELL	$1.27 - $2.23 $5,222 - $9,169	-4,112 Reduced 20.76%	15,700 $23,000
Q3 2024 Nov 14, 2024	SELL	$1.27 - $2.23 $5,222 - $9,169	-4,112 Reduced 20.76%	15,700 $23,000
Q2 2024 May 14, 2025	BUY	$1.4 - $2.77 $5,756 - $11,390	4,112 Added 26.19%	19,812 $39,000
Q2 2024 Oct 17, 2024	SELL	$1.4 - $2.77 $8,390 - $16,600	-5,993 Reduced 23.22%	19,812 $39,000
Q2 2024 Aug 14, 2024	SELL	$1.4 - $2.77 $8,390 - $16,600	-5,993 Reduced 23.22%	19,812 $39,000

Q1 2024 Oct 17, 2024	BUY	$1.39 - $2.21 $8,330 - $13,244	5,993 Added 30.25%	25,805 $37,000
Q1 2024 Aug 16, 2024	BUY	$1.39 - $2.21 $14,045 - $22,332	10,105 Added 64.36%	25,805 $37,000
Q1 2024 May 15, 2024	BUY	$1.39 - $2.21 $14,045 - $22,332	10,105 Added 64.36%	25,805 $37,000
Q4 2023 Aug 16, 2024	SELL	$1.56 - $2.24 $6,414 - $9,210	-4,112 Reduced 20.76%	15,700 $35,000
Q4 2023 Feb 13, 2024	BUY	$1.56 - $2.24 $4,834 - $6,941	3,099 Added 24.59%	15,700 $35,000
Q1 2023 May 15, 2023	SELL	$1.15 - $3.0 $5,740 - $14,976	-4,992 Reduced 28.37%	12,601 $37,000
Q4 2022 Feb 14, 2023	BUY	$1.46 - $2.94 $5,098 - $10,266	3,492 Added 24.76%	17,593 $27,000
Q3 2022 Nov 14, 2022	BUY	$1.83 - $2.93 $1,460 - $2,338	798 Added 6.0%	14,101 $34,000
Q2 2022 Oct 27, 2022	BUY	$1.77 - $3.87 $14,352 - $31,381	8,109 Added 156.12%	13,303 $25,000
Q2 2022 Aug 15, 2022	BUY	$1.77 - $3.87 $14,352 - $31,381	8,109 Added 156.12%	13,303 $25,000
Q1 2022 Oct 27, 2022	SELL	$3.56 - $6.66 $28,868 - $54,005	-8,109 Reduced 60.96%	5,194 $20,000
Q1 2022 May 13, 2022	SELL	$3.56 - $6.66 $27,810 - $52,027	-7,812 Reduced 60.06%	5,194 $20,000
Q4 2021 Feb 14, 2022	SELL	$4.94 - $7.69 $192,062 - $298,979	-38,879 Reduced 74.93%	13,006 $79,000
Q3 2021 Nov 15, 2021	BUY	$5.3 - $7.89 $274,990 - $409,372	51,885 New	51,885 $275,000

Others Institutions Holding SCYX

# of Institutions

Shares Held

12.5M

Call Options Held

Put Options Held

View Full List

About SCYNEXIS INC

Ticker SCYX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 32,651,800
Market Cap $19.3M
Description
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...

More about SCYX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account